News & Analysis on Clinical Trial Services & Contract Research And Development
John Horkulak - Celerion
By Dan Stanton
- Last updated on
Clinical research firm Celerion has appointed John Horkulak as Executive Director, Eurasian Site Operations, focusing on identifying and building partnerships with specialist early phase organizations with proven access to target patient populations.
He has over 30 years of experience in drug development for both pharma and CROs and Celerion’s VP Global Drug Development Fred Pritchard welcomed him to the team:
“His comprehensive knowledge and hands-on operational experience in conducting early phase studies in patients, particularly across emerging geographic regions, will complement Celerion’s efforts in North America and Europe to deliver on our clients’ needs for patient studies.”